Predicate |
Object |
assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_12a9e9ce63eb0bbf3658453fb50a6d9b |
classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K2317-92 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K2317-76 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K2317-24 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K2039-54 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K2039-505 |
classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K16-2866 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P17-06 |
classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P17-06 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K16-28 |
filingDate |
2019-03-08-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_9dbb184afba89939695427cfab7a12b1 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_68fa675399babd5267fd81ab47094aeb http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_e03f32122345c072c11728bafef97f84 |
publicationDate |
2019-09-19-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber |
US-2019284285-A1 |
titleOfInvention |
Use of anti-il-36r antibodies for treatment of generalized pustular psoriasis |
abstract |
The present invention relates to the treatment of or alleviation of signs and symptoms of an acute phase flare-up of generalized pustular psoriasis (GPP) with anti-IL36R antibodies. |
isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2022281987-A1 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2022187434-A1 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11130814-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-112180007-A http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2022072267-A1 |
priorityDate |
2018-03-14-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type |
http://data.epo.org/linked-data/def/patent/Publication |